Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
165 Leser
Artikel bewerten:
(0)

Retinal Surgery Devices Market to Reach $3 Billion by 2025 - Witnessing Unprecedented Growth Due to Growing Prevalence of Retinal Eye Disorders - Research and Markets

DUBLIN, May 22, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Retinal Surgery Devices Market, 2014 - 2025" report to their offering.

Research and Markets logo

The global retinal surgery devices market is expected to reach USD 3.06 billion by 2025.

The unprecedented growth is presumed to be a consequence of growing prevalence of retinal eye disorders such as retinal detachment, macular degeneration, amblyopia, and others. Rising patient preference for minimally invasive surgeries is believed to be one of the major growth contributory factors. The increasing demand is predicted to be a result of associated benefits such as improved cost-efficiency, safety, rapid recovery, efficacy, and reduced hospital stay. Other advantages include less incision wounds and reduced postsurgical complications that lead to higher patient satisfaction.

The market is also driven by technological upgradations that are responsible for heightened inclination of physicians, thereby, widening the scope for greater adoption of retinal surgery devices in future. The technologically advanced devices are equipped with fundus imaging units, micro incision technology, endoillumination systems. These advancements are primarily witnessed in surgical instrumentation to facilitate easy & safe operative procedure. For instance, launch of VersaVIT 2.0 vitrectomy machine which is equipped with LED illumination system, 3 vitrectomy packs and adjustable chandelier fiber. Similarly, 23-Gauge fragmentation needle that eliminates the need to enlarge sclerotomy and achieve enhanced visualization, intraoperative efficiency and control.


Companies Mentioned

  • Alcon, Inc.
  • Bausch & Lomb Incorporated
  • Carl Zeiss
  • Topcon Corporation
  • Synergetics USA, Inc.
  • IRIDEX Corporation
  • Ellex Medical Lasers
  • Escalon Medical
  • Second Sigh Medical Products
  • Erbe Elektromedizin

Key Topics Covered:

1 Research Methodology & Scope

2 Executive Summary

3 Retinal Surgery Devices Market Variables, Trends & Scope

4 Retinal Surgery Devices: Product Estimates & Trend Analysis

5 Retinal Surgery Devices: Application Estimates & Trend Analysis

6 Retinal Surgery Devices: End-use Estimates & Trend Analysis

7. Retinal Surgery Devices: Regional Estimates & Trend Analysis

8 Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/sk87wh/retinal_surgery

Media Contact:


Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.